RecruitingPhase IIEN originalLymphomaLeukemia

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This phase II trial studies the side effects and how well combination chemotherapy works in treating patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, Burkitt lymphoma/leukemia, or double-hit lymphoma/leukemia that has come back or does not respond to treatment. Drugs used in chemotherapy, such as clofarabine, etoposide, cyclophosphamide, vincristine sulfate liposome, dexamethasone and bortezomib, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Białaczka limfoblastyczna lub chłoniak limfoblastyczny, który wrócił lub nie reaguje na leczenie
  • Wiek powyżej 15 lat
  • Co najmniej 21 dni od poprzedniej chemioterapii (lub 14 dni w przypadku szybko rosnących nowotworów)
  • Funkcja wątroby: bilirubina do 1,5 mg/dL
  • Funkcja wątroby: transaminaza SGPT do 3-krotności normy
  • Funkcja nerek: czyszczenie kreatyniny co najmniej 50 mL/min
  • Ogólny stan zdrowia pozwalający na leczenie (skala ECOG do 3)
  • Podpisana świadoma zgoda na udział w badaniu

✗ Disqualifies

  • Ciężkie uszkodzenie nerwów obwodowych (stopień 3 lub wyższy)
  • Czynna choroba przeszczepienia przeciwko gospodarzowi w wątrobie
  • Zakażenie wirusem zapalenia wątroby B lub C
  • Ciąża lub karmienie piersią

Simplified criteria — AI translation

Trial details

Minimum age
15 Years
Last updated (source)
August 10, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

M D Anderson Cancer Center

Houston, United States

Trial contact

Maro Ohanian

PRINCIPAL_INVESTIGATOR

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.